...Shionogi antibiotic FDA accepted and granted Priority Review to an sNDA for Fetroja cefiderocol from Shionogi & Co. Ltd.... ...and Robin Sawka, BioCentury Staff
Piqray, alpelisib (BYL719)
Rozlytrek, entrectinib (RG6268, rxdx-101)
Johnson & Johnson
Novartis AG
AbbVie Inc.
Neurocrine Biosciences Inc.
Shionogi & Co. Ltd.
AstraZeneca...
...2H19 for its IV artesunate, LJPC-0118, to treat severe malaria. Shionogi acquires CNS partner Tetra Shionogi & Co. Ltd.... ...acquire neurology company Tetra Therapeutics for up to $500 million in regulatory and commercial milestones. Shionogi... ...disease and is in Phase II testing for Fragile X syndrome. Under a 2018 deal, Shionogi...
...treat cluster headaches with Emgality in its February roundup, which included a positive opinion on Shionogi’s... ...to prevent episodic cluster headaches. CHMP’s positive opinions included an MAA for Fetcroja cefiderocol from Shionogi & Co. Ltd.... ...galcanezumab-gnlm (LY2951742)
Vargatef, nintedanib (BIBF 1120, ofev, BIBF1120)
Alunbrig (Brand), AP26113 (Compound #), brigatinib (Generic)
Eli Lilly and Co.
Shionogi & Co. Ltd.
Boehringer...
...Shionogi antibiotic FDA accepted and granted Priority Review to an sNDA for Fetroja cefiderocol from Shionogi & Co. Ltd.... ...and Robin Sawka, BioCentury Staff
Piqray, alpelisib (BYL719)
Rozlytrek, entrectinib (RG6268, rxdx-101)
Johnson & Johnson
Novartis AG
AbbVie Inc.
Neurocrine Biosciences Inc.
Shionogi & Co. Ltd.
AstraZeneca...
...2H19 for its IV artesunate, LJPC-0118, to treat severe malaria. Shionogi acquires CNS partner Tetra Shionogi & Co. Ltd.... ...acquire neurology company Tetra Therapeutics for up to $500 million in regulatory and commercial milestones. Shionogi... ...disease and is in Phase II testing for Fragile X syndrome. Under a 2018 deal, Shionogi...
...treat cluster headaches with Emgality in its February roundup, which included a positive opinion on Shionogi’s... ...to prevent episodic cluster headaches. CHMP’s positive opinions included an MAA for Fetcroja cefiderocol from Shionogi & Co. Ltd.... ...galcanezumab-gnlm (LY2951742)
Vargatef, nintedanib (BIBF 1120, ofev, BIBF1120)
Alunbrig (Brand), AP26113 (Compound #), brigatinib (Generic)
Eli Lilly and Co.
Shionogi & Co. Ltd.
Boehringer...